High rates of adherence and treatment success in a public and public-private HIV clinic in India: Potential benefits of standardized national care delivery systems

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Shet, Anita ^a,b   Decosta, Ayesha ^a,b   Heylen, Elsa ^c   Shastri, Suresh ^d   Chandy, Sara ^e   Ekstrand, Maria ^a,c  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d National AIDS Control Organization   (India)

^e St Johns National Academy of Health Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PUBLIC-PRIVATE PARTNERSHIP; QUALITATIVE RESEARCH; STATISTICS; TREATMENT OUTCOME;

ADULT; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIVATE SECTOR; PUBLIC SECTOR; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; QUALITATIVE RESEARCH; TREATMENT OUTCOME;

EID: 80054070942     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-277     Document Type: Article

References (29)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS Epidemic update, 2009 http://data.unaids.org/pub/ Report/2009/jc1700-epi-update-2009-en.pdf
2. Address by Kofi Annan to the African Summit on HIV/AIDS, Tuberculosis and Other Infectious Diseases, Abuja, Nigeria, 2001 http://www.un.org/News/ossg/sg/ stories/statments-search-full.asp?statID=8 Accessed on 29 April 2011. 2001.
3. National AIDS Control Organization, Annual Report, 2009-2010, http://nacoonline.org/upload/AR%202009-10/NACO-AR-English%20corrected.pdf Accessed on 26 April 2011.
4. Ministry of Health and Family Welfare, Government of India. National AIDS Control Organization. Antiretroviral therapy guidelines for HIV infected adults and adolescents including post-exposure prophylaxis, 2007 http://www. nacoonline.org/About-NACO/Policy-Guidelines/
5. 'Where is the public health sector?' Public and private sector healthcare provision in Madhya Pradesh, India. De Costa A, Diwan V, Health Policy 2007 84 2-3 269 276 10.1016/j.healthpol.2007.04.004 17540472 (Pubitemid 47633711)
6. Healthcare financing: approaches and trends in India. Bajpai V, Saraya A, Natl Med J India 23 4 231 235
7. Private Sector Utilization of HIV/AIDS Services & Health Expenditures by People Living with HIV/AIDS in India: Findings from Five High-Prevalence States. Private sector partnerships-one. United States Agency for International Development (USAID), Sept 2009., 2009 http://shopsproject.org/sites/default/ files/resources/5347-file-FINAL-India-Brief.pdf
8. Private healthcare in developing countries: HIV/AIDS, 2008 http://ps4h.org/hiv-aids.html Accessed on 28 April 2011.
9. Suboptimal adherence associated with virologic failure and resistance mutations among patients on 1st line HAART in Bangalore, India. Ekstrand ML, Shet A, Chandy S, Singh G, Shamsundar R, Madhavan V, Saravanan S, Heylen E, Kumarasamy N, International Health 2011 3 27 34 10.1016/j.inhe.2010.11.003 21516199
10. Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study. Ekstrand ML, Chandy S, Heylen E, Steward W, Singh G, J Acquir Immune Defic Syndr 2010 53 3 415 416 10.1097/QAI.0b013e3181ba3e4e 20190588
11. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, Barta W, Fisher JD, J Acquir Immune Defic Syndr 2006 42 4 455 459 10.1097/01.qai.0000225020.73760.c2 16810111 (Pubitemid 44050893)
12. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR, HIV Clin Trials 2004 5 2 74 79 10.1310/JFXH-G3X2-EYM6-D6UG 15116282 (Pubitemid 38697081)
13. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. Balakrishnan P, Kumarasamy N, Kantor R, Solomon S, Vidya S, Mayer KH, Newstein M, Thyagarajan SP, Katzenstein D, Ramratnam B, AIDS Res Hum Retroviruses 2005 21 4 301 305 10.1089/aid.2005.21.301 15943572 (Pubitemid 40632362)
14. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, et al. J Acquir Immune Defic Syndr 2003 34 3 281 288 10.1097/00126334-200311010-00004 14600572 (Pubitemid 37377361)
15. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, Shah R, Shao HJ, Morpeth SC, McNeill JD, et al. Clin Infect Dis 2007 45 11 1492 1498 10.1086/522991 17990233 (Pubitemid 351411882)
16. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Shah B, Walshe L, Saple DG, Mehta SH, Ramnani JP, Kharkar RD, Bollinger RC, Gupta A, Clin Infect Dis 2007 44 9 1235 1244 10.1086/513429 17407045 (Pubitemid 46651251)
17. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AK, Solomon S, Mayer KH, AIDS Patient Care STDS 2005 19 8 526 537 10.1089/apc.2005.19.526 16124847 (Pubitemid 41262633)
18. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, et al. Lancet 2006 367 9513 817 824 16530575
19. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. Pradier C, Bentz L, Spire B, Tourette-Turgis C, Morin M, Souville M, Rebillon M, Fuzibet JG, Pesce A, Dellamonica P, et al. HIV Clin Trials 2003 4 2 121 131 10.1310/BRBV-3941-H1PP-NDRY 12671780 (Pubitemid 36410916)
20. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, Glazier RH, Cochrane Database Syst Rev 2006 3 D001442 16855968
21. National AIDS Control Programme, Phase III (2006-2011), Ministry of Health and Family Welfare, Government of India, 2006 http://www.nacoonline.org/ upload/Publication/Strategy%20and%20Implementation%20Plan%20- %20NACO%20Programme%20Phase%20III%20%282006-2011%29%202006.pdf Accessed on 26 April 2011.
22. Operational guidelines for ART centers, National AIDS Control Organisation, Ministry of Health & Family Welfare, Government of India, 2007 http://www.nacoonline.org/Quick-Links/Publication/Treatment-Care-Support/ Operational-Technical-guidelines-and-policies/Operational-Guidelines-for-ART- Centers/
23. UNGASS Country Progress Report: India. National AIDS Control Organization India (2010), New Delhi, India, 2010 http://www.unaids.org/en/dataanalysis/ monitoringcountryprogress/2010progressreportssubmittedbycountries/ india-2010-country-progress-report-en.pdf Accessed on 20 April 2011.
24. Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme. Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, Deshpande A, Emmanuel KV, Chan P, Rao KS, Natl Med J India 23 1 7 12
25. Public-private partnerships for health: a review of best practices in the health sector, World Bank 2003, 2003 http://www.bvsde.paho.org/bvsacd/cd27/ private.pdf Accessed on 20 April 2011.
26. Can public-private partnerships improve health in India? Ghanashyam B, Lancet 2008 372 9642 878 879 10.1016/S0140-6736(08)61380-X 18795418
27. Public-private partnerships and global health equity: prospects and challenges. Asante AD, Zwi AB, Indian J Med Ethics 2007 4 4 176 180 18630239
28. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C, PLoS Med 2006 3 11 438 10.1371/journal.pmed.0030438 17121449 (Pubitemid 44875939)
29. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam J, Indian J Med Res 2008 127 1 28 36 18316850 (Pubitemid 351663563)